Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients

NCT02654483 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Epidermolysis Bullosa
Pruritus

Interventions

DRUG: VPD-737
OTHER: Placebo

Sponsor

Jean Yuh Tang

Collaborators

[object Object]
[object Object]